JDQ443
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for JDQ443, covering 2025-10-09 to 2026-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer [Phase 3]